Print Page     Close Window     

SEC Filings

10-K/A
BIOTIME INC filed this Form 10-K/A on 03/29/2017
Entire Document
 

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a-1)
Financial Statements.

The following financial statements of BioTime, Inc. are filed in the Form 10-K:
Consolidated balance sheets
Consolidated statements of operations
Consolidated statements of comprehensive loss
Consolidated statements of shareholders’ equity
Consolidated statements of cash flows
Notes to Consolidated Financial Statements

(a-3)
Exhibits.

Exhibit
Numbers
 
Description
     
3.1
 
Articles of Incorporation with all amendments (1)
     
3.2
 
By-Laws, As Amended (2)
     
4.1
 
Specimen of Common Share Certificate (3)
     
4.2
 
Form of Warrant Issued June 2013 (4)
     
4.3
 
Warrant Agreement, dated as of October 1, 2013, as amended September 19, 2014, between BioTime, Inc. and American Stock Transfer & Trust Company, LLC as Warrant Agent for the benefit of Asterias Biotherapeutics, Inc. (5)
     
4.4
 
Warrant Issued October 1, 2013 to Asterias Biotherapeutics, Inc. (included in Exhibit 4.7) (5)
     
10.1
 
Intellectual Property Agreement between BioTime, Inc. and Hal Sternberg (3)
     
10.2
 
Intellectual Property Agreement between BioTime, Inc. and Judith Segall (3)
     
10.3
 
2002 Stock Option Plan, as amended (6)
     
10.4
 
Employment Agreement, dated October 10, 2007, between BioTime, Inc. and Michael D. West. (7)
     
10.5
 
Commercial License and Option Agreement between BioTime and Wisconsin Alumni Research Foundation (8)
     
10.6
 
License Agreement, dated July 10, 2008, between Embryome Sciences, Inc. and Advanced Cell Technology, Inc. (9)
     
10.7
 
First Amendment of Commercial License and Option Agreement, dated March 11, 2009, between BioTime and Wisconsin Alumni Research Foundation (10)
     
10.8
 
Amended and Restated Shareholders Agreement, dated October 7, 2010, by and among ES Cell International Pte. Ltd., BioTime, Inc., Teva Pharmaceutical Industries, Limited, HBL-Hadasit Bio-Holdings, Ltd., and Cell Cure Neurosciences Ltd. (11)
 

© Copyright BioTime, Inc.